CompletedNCT06122766
NGLY1 Natural History
Studying Alacrimia-choreoathetosis-liver dysfunction syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Baylor College of Medicine
- Principal Investigator
- Bernhard Suter, MD, M.DBaylor College of Medicine
- Enrollment
- 15 enrolled
- Eligibility
- 2-25 years · All sexes
- Timeline
- 2023 – 2024
Study locations (1)
- Texas Children's Hospital, Houston, Texas, United States
Collaborators
Grace Science Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06122766 on ClinicalTrials.govOther trials for Alacrimia-choreoathetosis-liver dysfunction syndrome
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT05402345A Study of GlcNAc on Tear Production in NGLY1-CDDGEva Morava-Kozicz
- RECRUITINGPHASE1, PHASE2NCT06199531Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 DeficiencyGrace Science, LLC
See all trials for Alacrimia-choreoathetosis-liver dysfunction syndrome →